AQR Arbitrage’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

AQR Arbitrage’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Hold	282,120	–	–	﹤0.01%	412
2026 Q1	$212K	Sell	282,120 -8,030	-3%	-$6.28K	﹤0.01%	385
2025 Q4	$206K	Sell	290,150 -105,907	-27%	-$88.4K	﹤0.01%	375
2025 Q3	$297K	Hold	396,057	–	–	0.01%	322
2025 Q2	$339K	Hold	396,057	–	–	0.01%	278
2025 Q1	$297K	Buy	396,057 +1	+0%	+$1	0.01%	271
2024 Q4	$285K	Buy	+396,056	New	+$259K	0.01%	305

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

AQR Arbitrage's OACCW Position: Q2 2026 in Review

AQR Arbitrage held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q2 2026 at 282,120 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #412.

AQR Arbitrage first reported a position in OACCW in Q4 2024 and has held it in 7 quarters since. The position peaked at $339K in Q2 2025. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

AQR Arbitrage held 282,120 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $251K as of Q2 2026.
AQR Arbitrage left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q2 2026.
Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of AQR Arbitrage's portfolio in Q2 2026, its #412 holding.
AQR Arbitrage first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 7 quarters since.
AQR Arbitrage's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $339K in Q2 2025.
27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.